D.E. Shaw & Co’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$95.4K Buy
55,471
+16,195
+41% +$27.9K ﹤0.01% 2898
2025
Q1
$131K Buy
39,276
+8,464
+27% +$28.2K ﹤0.01% 2820
2024
Q4
$228K Sell
30,812
-36,936
-55% -$273K ﹤0.01% 2693
2024
Q3
$636K Sell
67,748
-588,082
-90% -$5.52M ﹤0.01% 2378
2024
Q2
$5.26M Sell
655,830
-1,696,336
-72% -$13.6M ﹤0.01% 1238
2024
Q1
$34.9M Buy
2,352,166
+2,137,032
+993% +$31.7M 0.03% 393
2023
Q4
$1.75M Buy
215,134
+177,372
+470% +$1.44M ﹤0.01% 1804
2023
Q3
$172K Sell
37,762
-820,994
-96% -$3.74M ﹤0.01% 2611
2023
Q2
$6.05M Sell
858,756
-1,501,195
-64% -$10.6M 0.01% 1157
2023
Q1
$14.4M Sell
2,359,951
-1,861,809
-44% -$11.4M 0.02% 742
2022
Q4
$27M Buy
4,221,760
+1,526,540
+57% +$9.75M 0.03% 463
2022
Q3
$25.8M Buy
2,695,220
+617,689
+30% +$5.92M 0.03% 459
2022
Q2
$22.9M Buy
2,077,531
+1,952,904
+1,567% +$21.6M 0.03% 542
2022
Q1
$2.08M Buy
124,627
+52,590
+73% +$876K ﹤0.01% 2402
2021
Q4
$1.38M Buy
72,037
+62,523
+657% +$1.19M ﹤0.01% 2579
2021
Q3
$235K Sell
9,514
-16,072
-63% -$397K ﹤0.01% 3180
2021
Q2
$666K Sell
25,586
-212,183
-89% -$5.52M ﹤0.01% 2746
2021
Q1
$7.53M Buy
237,769
+108,988
+85% +$3.45M 0.01% 1154
2020
Q4
$5.98M Buy
128,781
+82,391
+178% +$3.82M 0.01% 1222
2020
Q3
$1.53M Buy
+46,390
New +$1.53M ﹤0.01% 1728
2020
Q2
Sell
-26,715
Closed -$800K 2714
2020
Q1
$800K Buy
26,715
+4,526
+20% +$136K ﹤0.01% 1961
2019
Q4
$614K Buy
+22,189
New +$614K ﹤0.01% 2107
2018
Q4
Sell
-22,754
Closed -$256K 2645
2018
Q3
$256K Buy
+22,754
New +$256K ﹤0.01% 2301
2017
Q1
Sell
-14,778
Closed -$103K 2506
2016
Q4
$103K Buy
+14,778
New +$103K ﹤0.01% 2405
2016
Q2
Sell
-17,176
Closed -$87K 2588
2016
Q1
$87K Buy
17,176
+3,282
+24% +$16.6K ﹤0.01% 2490
2015
Q4
$107K Sell
13,894
-3,854
-22% -$29.7K ﹤0.01% 2527
2015
Q3
$102K Sell
17,748
-6,159
-26% -$35.4K ﹤0.01% 2447
2015
Q2
$219K Buy
+23,907
New +$219K ﹤0.01% 2444